HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

The management of granulosa-cell tumors of the ovary based on long-term follow up.

Abstract
The results of treatment in 130 cases of GCT of the ovary treated in the Institute of Oncology in Warsaw and followed up from 5 to 40 years were analysed with respect to the methods of therapy and age of the patients. The highest 5-year survival rate (86%) was obtained by combination of radical surgery with external irradiation. Such treatment also resulted in the lowest percentage of early and late failures of the treatment (17%). Conservative surgery, applied in the Ist stage of GCT resulted in 69% of 5-year survivals and gave young women a chance of procreation; however, the majority (69%) of patients who underwent this treatment sooner or later developed a recurrence leading, in consequence, to death.
AuthorsZ Kietlińska, K Pietrzak, M Drabik
JournalEuropean journal of gynaecological oncology (Eur J Gynaecol Oncol) Vol. 14 Suppl Pg. 118-27 ( 1993) ISSN: 0392-2936 [Print] Singapore
PMID8200362 (Publication Type: Journal Article)
Topics
  • Adolescent
  • Adult
  • Age Factors
  • Aged
  • Aged, 80 and over
  • Cause of Death
  • Combined Modality Therapy
  • Female
  • Follow-Up Studies
  • Granulosa Cell Tumor (mortality, pathology, radiotherapy, surgery)
  • Humans
  • Middle Aged
  • Neoplasm Metastasis
  • Neoplasm Recurrence, Local (epidemiology, therapy)
  • Neoplasm Staging
  • Neoplasms, Second Primary (mortality)
  • Ovarian Neoplasms (mortality, pathology, radiotherapy, surgery)
  • Poland (epidemiology)
  • Remission Induction
  • Salvage Therapy
  • Survival Rate
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: